Acupressure for Persistent Cancer Related Fatigue
Suzanna M. Zick, N.D., M.P.H., Principal Investigator
Ananda Sen, Ph.D., Co-Investigator
Funded by the National Institutes of Health, The National Cancer Institute
This randomized, single-blind, placebo controlled study will examine the effect of two different acupressure treatments compared to standard of care, since self-administered acupressure has been demonstrated to decrease persistent cancer-related fatigue (PCRF) for breast cancer survivor
Modeling Professional Attitudes and Teaching Humanistic Communication in Virtual Reality (MPathic VR)
Michael D. Fetters, M.D., M.P.H., M.A., Principal Investigator
Funded by The National Institutes of Health
The M-Pathic VR II project will rigorously evaluate the extent that the newly successful "virtual reality" software program (developed in Phase I) can enhance medical school curricula in professionalism, empathy, and in patient-centeredness (using verbal and non-verbal communication skills) as well as the ACGME competencies when treating a terminally ill cancer patient.
Multi-Level Approaches to Screening for Colorectal and Cervical Cancers in Rural Primary Care Settings
Sherri Sheinfeld Gorin, Ph.D., FSBM., PI | [email protected] and [email protected]
Masahito Jimbo, M.D., Ph.D., M.P.H., Co-PI | [email protected]
Funded by the Michigan Institute for Clinical & Health Research
The goal of the MICHR Accelerating Synergy Positioning Project (called the Primary Care Rural Screening Project ,PCRSP) is to advance understanding of the multi-level healthcare policy, institution, physician, provider team, and patient factors that contribute to colorectal, cervical, and lung cancer-related health disparities in incidence and mortality among rural populations, and the implications of these inequities.
Translational Research in GI Cancer
Ananda Sen, Ph.D., Co-Investigator
Zora Djuric, Ph.D., Co-Investigator
Funded by the National Institutes of Health
The Specialized Program of Research Excellence will address the hypothesis that identifying and developing interventions to address molecular events that enhance cellular carcinogenesis or cellular transformed phenotype will reduce the morbidity and mortality associated with colorectal and pancreatic cancers through risk identification, preventive interventions, early detection, or improved treatment of invasive cancer.
